At Pollen Ventures, we have amassed a wealth of continually evolving business knowledge from our experience working on critical issues in high growth companies.  We focus our practice in select areas of expertise, with a worldwide network of individuals, working collaboratively, who collect insights from client work, conduct new research, and disseminate knowledge both internally and externally.  These networks are structured around business functions as well as key issues that are relevant to high growth companies.

As pollen creates a seed, Pollen Ventures facilitates the emerging high tech company to accelerate its transition into a best-of-class company.

We are often asked what makes a company interesting enough that Pollen Ventures would choose to back it. There is no simple answer to that question. The investment decision process is more art than science, and involves the intuition, analysis, and judgment of all of our partners. The venture capitalist-management relationship is heavily influenced by trust, respect, personal chemistry, and shared vision. We do not back products, nor do we invest in markets alone. Pollen's business is to invest in people who create pioneering products, and who have the intent to build a lasting company by serving customers with excellence.

There is no formula for the "perfect" venture capital investment. However, Pollen does look for a few key elements in each company we back. Most notably:

• A large, definable, approachable market
• An expectation for the company to achieve market leadership
• Breakthrough and protectable technology to address the market
• Outstanding people who understand the importance of a balanced team in building a successful company

At Pollen, we have observed that success is virtually never achieved in a straight line. Therefore, the most successful founders, managers and venture capitalists must bring to their business:

• A superb ability to be in tune to the pulse of present and future market needs,
• The flexibility to change rapidly as technologies and markets evolve, and
• The execution skills to brilliantly implement against goals.

We attempt to assess these attributes, and others, each time we evaluate a founding team.

Over the past 21 years, our investment focus and expertise has centered on one primary area: Life Science.